We identified a cluster of IGHA1+ plasma cells (BC-F: TNFRSF17 + MZB1 + CD24−CD38hi) which expressed higher levels of maturation markers in flare compared to DFR patients. This evidence concerns the gene TNFRSF17 and breast cancer.